What pain management options are appropriate for a 70‑year‑old woman with longstanding rheumatoid arthritis and wrist pain, who is on amlodipine 10 mg daily, low‑dose aspirin after a prior stroke, and has not used glucocorticoids since a brief prednisone course?

Pain Management for RA with Cardiovascular Comorbidity

For this 70-year-old woman with longstanding RA, wrist pain, prior stroke, and no recent glucocorticoid use, start with acetaminophen up to 4 g daily as first-line therapy, and urgently refer back to rheumatology to optimize DMARD therapy, as pain control fundamentally depends on controlling the underlying inflammatory disease.

Immediate Pain Management Strategy

First-Line Analgesic Approach

Acetaminophen (paracetamol) is the safest initial choice given her cardiovascular history and concurrent aspirin use 1, 2. Start with:

• 1000 mg three times daily (maximum 4 g/24 hours from all sources)
• This provides effective analgesia for RA pain without the cardiovascular, renal, or gastrointestinal risks of NSAIDs 1
• Educate the patient on maximum safe dosing and to check all over-the-counter medications for hidden acetaminophen content

Critical Caveat: NSAIDs and Cardiovascular Risk

NSAIDs should be avoided or used with extreme caution in this patient 3, 2:

• She has documented stroke history and is on aspirin for secondary prevention
• All NSAIDs (both traditional and COX-2 selective) carry increased cardiovascular risk, particularly problematic post-stroke 4, 5
• If NSAIDs become absolutely necessary despite acetaminophen failure, use the lowest effective dose for the shortest possible duration 3
• Topical NSAIDs for the wrist would be safer than oral formulations if localized treatment is needed 2

Disease-Modifying Strategy (Most Important)

Urgent Rheumatology Re-engagement

The fundamental problem is inadequate disease control, not just symptom management 3, 6:

• She hasn't seen rheumatology since [DATE] and has no upcoming appointment until [DATE]—this gap is unacceptable
• Contact rheumatology immediately to expedite her appointment or arrange interim assessment
• Pain in RA primarily reflects active inflammation; controlling disease activity is the definitive pain treatment 3, 7, 6

DMARD Optimization Required

Based on EULAR and ACR guidelines 3, 6:

• Methotrexate should be the anchor DMARD if not already optimized
• If she's not on any DMARDs currently, this represents a critical treatment gap
• The brief prednisone course in [DATE] suggests previous disease activity that may not have been adequately addressed with DMARDs

Glucocorticoid Considerations

Short-Term Bridging Therapy

A brief course of low-dose prednisone may be appropriate as bridging therapy while optimizing DMARDs 3, 7:

• Prednisone 5-10 mg daily for 2-4 weeks maximum 7, 8
• This can provide rapid symptom relief while waiting for DMARD effects
• Must be temporary (<6 months) and at the lowest effective dose 3, 4
• Given her cardiovascular history, minimize duration and dose due to metabolic effects

Intra-articular Injection Alternative

For isolated wrist pain, consider intra-articular glucocorticoid injection 3, 4, 2:

• Provides localized relief without systemic exposure
• Particularly appropriate for monoarticular or oligoarticular flares
• Can be performed in primary care or by rheumatology
• Safer than systemic steroids given her comorbidities

Opioid Considerations (Use Cautiously)

Weak opioids may be considered if acetaminophen fails and NSAIDs are contraindicated 9, 10, 11:

• Options include tramadol or codeine combinations
• Start at lower doses in elderly patients (she's 70 years old) with slower titration 1, 10
• Monitor closely for:
  • Constipation (prophylactic laxatives recommended) 11
  • Cognitive effects and fall risk 1
  • Drug interactions with amlodipine (both can cause dizziness)
• This should be short-term only while disease control is optimized

What NOT to Do

Avoid These Common Pitfalls:

1. Do not continue inadequate pain management without addressing underlying disease activity 3, 6
2. Do not use chronic NSAIDs in this stroke patient 4, 5
3. Do not use long-term glucocorticoids (>6 months or >10 mg/day prednisone equivalent) 3, 7, 12
4. Do not delay rheumatology follow-up—the [DATE] appointment is too far away for active disease 3

Monitoring and Follow-Up

Establish clear follow-up within 2-4 weeks to assess:

• Pain response to acetaminophen
• Functional status and ability to perform daily activities
• Need for escalation to additional therapies
• Confirmation of rheumatology appointment status
• Any adverse effects from new medications

If pain persists despite acetaminophen and she cannot see rheumatology sooner, consider:

• Adding topical NSAIDs to the wrist specifically 2
• Short-term low-dose prednisone (5-7.5 mg daily) for 2-4 weeks 7, 8
• Intra-articular wrist injection if accessible 3, 2

The key principle is that effective RA pain management requires controlling the underlying inflammatory disease 3, 6, 13. Symptomatic pain treatment alone, while necessary in the short term, is insufficient without optimizing her DMARD therapy.